Literature DB >> 27707621

Predictors of intervention and mortality in patients with uncomplicated acute type B aortic dissection.

Hunter M Ray1, Christopher A Durham1, Daniel Ocazionez1, Kristofer M Charlton-Ouw1, Anthony L Estrera1, Charles C Miller1, Hazim J Safi1, Ali Azizzadeh2.   

Abstract

OBJECTIVE: Patients with uncomplicated acute type B aortic dissection (uATBAD) have historically been managed with medical therapy. Recent studies suggest that high-risk patients with uATBAD may benefit from thoracic endovascular aortic repair. This study aims to determine the predictors of intervention and mortality in patients with uATBAD.
METHODS: All patients admitted with uATBAD from 2000 to 2014 were reviewed, and those with computed tomographic angiography imaging were included. Multiplanar reconstruction was used to obtain double orthogonal oblique measurements. All measurements were obtained by a specialized cardiovascular radiologist (D.O.). The maximum aortic diameter, proximal descending thoracic aorta false lumen (FL) diameter, and area were recorded. Outcomes, including the need for intervention and mortality, were tracked over time. Data were analyzed by stratified Kaplan-Meier and multiple Cox regression analysis using SAS v 9.4 (SAS Institute, Cary, NC).
RESULTS: During the study period, 294 patients with uATBAD were admitted with 156 having admission computed tomographic angiography imaging available for analysis. The cohort had an average age of 60.6 years (±13.6 years); 60% were males. The average follow-up time was 3.7 years (interquartile range, 2.1-6.9). A stratified analysis demonstrated the most sensitive cutoff for mortality was aortic diameter >44 mm (P < .01), and it appeared to be a threshold effect with minimal additional information added by finer size stratification. FL diameter did not predict mortality in our series (P = .36). Intervention-free survival, alternatively, appeared to decrease over the range of diameters from 35 to 44 mm (P < .01). An FL diameter >22 mm was associated with decreased intervention-free survival (P < .04). Age >60 years on admission also demonstrated decreased survival compared with those ≤60 years of age (P < .01). Diameter >44 mm persisted as a risk factor for mortality (hazard ratio, 8.6; P < .01) after adjustment for diabetes (6.7; P < .01), age (1.06/y; P < .01), history of stroke (5.4; P < .01), connective tissue disorder (2.3; P < .01), and syncope on admission (9.5; P < .04). The 1-, 5-, and 10-year intervention rate for patients with admission aortic diameter >44 mm was 18.8%, 29.5%, and 50.3%, respectively, compared with 4.8%, 13.3%, and 13.3% in the ≤44 mm group (P < .01).
CONCLUSIONS: Aortic diameter >44 mm is a predictor of mortality after adjustment for other significant risk factors. Age >60 years on admission is a predictor of mortality. An FL diameter >22 mm as well as those with maximum aortic diameter >44 mm on admission were associated with decreased intervention-free survival. Patients with these high-risk criteria may benefit from thoracic endovascular aortic repair. Further studies are needed to further define those patients at highest risk and, thus, most likely to benefit from early intervention.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27707621     DOI: 10.1016/j.jvs.2016.07.111

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  13 in total

Review 1.  Indications for Thoracic EndoVascular Aortic Repair (TEVAR): A Brief Review.

Authors:  Frank Manetta; Joshua Newman; Allan Mattia
Journal:  Int J Angiol       Date:  2018-08-02

2.  Endovascular repair or best medical treatment: what is the optimal management of uncomplicated Type-B acute aortic dissection?

Authors:  María Elena Arnáiz-García; José María González-Santos; Ana María Arnáiz-García; Javier Arnáiz
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Left ventricular hypertrophy is a possible biomarker for early mortality after type B aortic dissection.

Authors:  Alexander P Taylor; Rosario V Freeman; Matthew A Bartek; Sherene Shalhub
Journal:  J Vasc Surg       Date:  2018-12-11       Impact factor: 4.268

4.  Predictors of Failure of Medical Management in Uncomplicated Type B Aortic Dissection.

Authors:  Xiaoying Lou; Yazan M Duwayri; Edward P Chen; William D Jordan; Jessica Forcillo; Carl A Zehner; Bradley G Leshnower
Journal:  Ann Thorac Surg       Date:  2018-10-04       Impact factor: 4.330

5.  Uncomplicated Acute Type B Aortic Dissection: Selection Guidelines for TEVAR.

Authors:  Emilia Krol; Jean M Panneton
Journal:  Ann Vasc Dis       Date:  2017-09-25

6.  How should we treat uncomplicated subacute type B aortic dissection in octogenarians?

Authors:  Ken Nakamura; Tetsuro Uchida; Azumi Hamasaki; Mitsuaki Sadahiro
Journal:  J Cardiothorac Surg       Date:  2019-02-26       Impact factor: 1.637

7.  Non-O blood group is associated with lower risk of in-hospital mortality in non-surgically managed patients with type A aortic dissection.

Authors:  Song Huang; Yequn Chen; Zhaotao Huang; Shiwan Wu; Nianling Xiong; Xiru Huang; Xin Wang; Chang Chen; Bin Wang; Weiping Li; Liangli Hong; Shu Ye; Xuerui Tan
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

8.  4D flow MRI of type B dissection with later retrograde progression to type A dissection in Marfan: a case report.

Authors:  Max J P van Hout; Joe F Juffermans; Arthur J Scholte; Hildo J Lamb
Journal:  Eur Heart J Case Rep       Date:  2021-08-27

9.  All type B aortic dissections should undergo thoracic endovascular aneurysm repair.

Authors:  Saket Singh; Naiem Nassiri; Prashanth Vallabhajosyula
Journal:  JTCVS Tech       Date:  2021-08-09

10.  Short term outcome of thoracic endovascular aortic repair in patients with thoracic aortic diseases.

Authors:  Hamdy Soliman; Mohammed N El-Ganainy; Reham M Darweesh; Sameh Bakhoum; Mohammed Abdel-Ghany
Journal:  Egypt Heart J       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.